Method for vascular embolization
First Claim
1. A method for vascular embolization of a blood vessel of a patient which comprises the steps of:
- (a) injecting, into the blood vessel of the patient, an aqueous solution containing from 0.5% to 50% by weight of a thermosensitive polymer consisting of the monomeric units comprising a monomeric moiety derived from an N-substituted (meth) acrylamide compound and represented by the general formula ##STR2## in which R1 is a hydrogen atom or a methyl group, R2 is a hydrogen atom, an alkyl group or an alkoxy-substituted alkyl group and R3 is an alkyl group or an alkoxy-substituted alkyl group, having an intrinsic viscosity [η
] in the range from 0.01 to 6.0 dl/g in tetrahydrofuran at 27°
C. and having a transition temperature for coagulation of the aqueous solution by the phase transition of the polymer into a coagulate within a range from 10°
to 37°
C., at a temperature lower than the transition therapeutically acceptable temperature; and
(b) heating the aqueous solution of the thermosensitive polymer inside of the blood vessel up to a temperature higher than the transition temperature of the thermosensitive polymer either externally or by the body temperature of the patient.
1 Assignment
0 Petitions
Accused Products
Abstract
Proposed is a method for vascular embolization of the blood vessel of a patient by introducing an aqueous solution of a specific thermosensitive polymer, which is liquid at low temperatures but causes coagulation when heated up to the body temperature of the patient, into the blood vessel followed by in situ heating of the solution. The thermosensitive polymer found to be suitable for the purpose is a homopolymer or copolymer of an N-substituted (meth) acrylamide monomer having a specified intrinsic viscosity in tetrahydrofuran and gives an aqueous solution capable of exhibiting phase transition from a liquid to a coagulate at a transition temperature of 10° to 37°.
-
Citations
5 Claims
-
1. A method for vascular embolization of a blood vessel of a patient which comprises the steps of:
-
(a) injecting, into the blood vessel of the patient, an aqueous solution containing from 0.5% to 50% by weight of a thermosensitive polymer consisting of the monomeric units comprising a monomeric moiety derived from an N-substituted (meth) acrylamide compound and represented by the general formula ##STR2## in which R1 is a hydrogen atom or a methyl group, R2 is a hydrogen atom, an alkyl group or an alkoxy-substituted alkyl group and R3 is an alkyl group or an alkoxy-substituted alkyl group, having an intrinsic viscosity [η
] in the range from 0.01 to 6.0 dl/g in tetrahydrofuran at 27°
C. and having a transition temperature for coagulation of the aqueous solution by the phase transition of the polymer into a coagulate within a range from 10°
to 37°
C., at a temperature lower than the transition therapeutically acceptable temperature; and(b) heating the aqueous solution of the thermosensitive polymer inside of the blood vessel up to a temperature higher than the transition temperature of the thermosensitive polymer either externally or by the body temperature of the patient. - View Dependent Claims (2, 3, 4, 5)
-
Specification